
DI SODIUM SUCCINATE HEXAHYDRATE USP-NF
Buffering agent and pH modifier developed exclusively for use in injectable formulations.Benefits:DMF Filed - CDE # F20200000141Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
Reliable excipients and APIs meeting stringent pharmaceutical standards. Supporting safe, effective and compliant drug formulations.
Sort by




Let’s build your next solution together